21 CFR Subpart E
Requirements for Specific New Drugs or Devices
June 25, 2020
§
310.501
Patient package inserts for oral contraceptives
§
310.502
Certain drugs accorded new drug status through rulemaking procedures
§
310.503
Requirements regarding certain radioactive drugs
§
310.509
Parenteral drug products in plastic containers
§
310.515
Patient package inserts for estrogens
§
310.517
Labeling for oral hypoglycemic drugs of the sulfonylurea class
§
310.518
Drug products containing iron or iron salts
§
310.519
Drug products marketed as over-the-counter (OTC) daytime sedatives
§
310.527
Drug products containing active ingredients offered over-the-counter (OTC) for external use as hair growers or for hair loss prevention
§
310.528
Drug products containing active ingredients offered over-the-counter (OTC) for use as an aphrodisiac
§
310.529
Drug products containing active ingredients offered over-the-counter (OTC) for oral use as insect repellents
§
310.530
Topically applied hormone-containing drug products for over-the-counter (OTC) human use
§
310.531
Drug products containing active ingredients offered over-the-counter (OTC) for the treatment of boils
§
310.532
Drug products containing active ingredients offered over-the-counter (OTC) to relieve the symptoms of benign prostatic hypertrophy
§
310.533
Drug products containing active ingredients offered over-the-counter (OTC) for human use as an anticholinergic in cough-cold drug products
§
310.534
Drug products containing active ingredients offered over-the-counter (OTC) for human use as oral wound healing agents
§
310.536
Drug products containing active ingredients offered over-the-counter (OTC) for use as a nailbiting or thumbsucking deterrent
§
310.537
Drug products containing active ingredients offered over-the-counter (OTC) for oral administration for the treatment of fever blisters and cold sores
§
310.538
Drug products containing active ingredients offered over-the-counter (OTC) for use for ingrown toenail relief
§
310.540
Drug products containing active ingredients offered over-the-counter (OTC) for use as stomach acidifiers
§
310.541
Over-the-counter (OTC) drug products containing active ingredients offered for use in the treatment of hypophosphatemia
§
310.542
Over-the-counter (OTC) drug products containing active ingredients offered for use in the treatment of hyperphosphatemia
§
310.543
Drug products containing active ingredients offered over-the-counter (OTC) for human use in exocrine pancreatic insufficiency
§
310.544
Drug products containing active ingredients offered over-the-counter (OTC) for use as a smoking deterrent
§
310.545
Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses
§
310.546
Drug products containing active ingredients offered over-the-counter (OTC) for the treatment and/or prevention of nocturnal leg muscle cramps
§
310.547
Drug products containing quinine offered over-the-counter (OTC) for the treatment and/or prevention of malaria
§
310.548
Drug products containing colloidal silver ingredients or silver salts offered over-the-counter (OTC) for the treatment and/or prevention of disease